|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,962 JPY | +1.37% |
|
+2.63% | +4.19% |
| Apr. 04 | Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen | MT |
| Apr. 04 | Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update | DJ |
Rohto Pharmaceutical Co.,Ltd. (TSE:4527) acquired 67.19% stake in Amato Pharmaceutical Products, Ltd. on June 8, 2021. As a part of the transaction, Rohto Pharmaceutical will acquire 0.86 million shares. For the period ended March 31, 2021, Amato Pharmaceutical Products reported sales of ¥5.9 billion.
The transaction is expected to be completed by August 31, 2021. JPMorgan Securities Japan Co., Ltd. acted as financial advisor to Amato Pharmaceutical Products, Ltd.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.19% | 4.3B | |
| +24.17% | 562B | |
| -6.42% | 358B | |
| +18.56% | 322B | |
| +7.20% | 297B | |
| +13.15% | 219B | |
| +6.07% | 199B | |
| -10.31% | 196B | |
| -11.20% | 149B | |
| -7.07% | 146B |
ROHTO PHARMACEUTICAL CO.,LTD. 
